Press Release February 13, 2007 Updated 5/16/2010 ANN ARBOR, Mich. — Genetic testing for eye disease is providing vital information about complex retinal diseases, especially when used to confirm a clinician’s diagnosis. In a newly published review of such tests that were conducted over a five-year period at the University of Michigan Kellogg Eye Center, [Read More]
News
Saffron Shown to Improve Vision
by Dan Roberts February 8, 2010 Clinical trials in Italy and Australia have shown that the spice, saffron, can improve vision in people with AMD. The trial was conducted Policlinico Gemelli in Italy by Professor Benedetto Falsini. It was double blind and randomly controlled, involving 25 subjects over six months. Half the group was given [Read More]
Study Shows Lucentis and Avastin to be Equal
by Dan Roberts February 3, 2010 Investigators at Kaiser Permanente Southern California in Pasadena reported in the February 2010 issue of Ophthalmology that Avastin and Lucentis performed equally in recent testing. In an indirect comparison of the two drugs, study author Dr. Donald Fong and coauthors reviewed the records of 452 patients treated for wet [Read More]
PEG-POD – New Gene Delivery Tool
by Dan Roberts January 2010 Researchers have developed a new tool for gene therapy that significantly increases gene delivery to cells in the retina compared to other carriers and DNA alone. The study was published in the January 2010 issue of The Journal of Gene Medicine by Tufts University School of Medicine and the Sackler [Read More]
Foresee Home Sets New Standard of Care for AMD Patients
by Dan Roberts Updated 3/1/2016 A relatively new technology, called preferential hyperacuity perimetry (PHP) allows eye doctors to detect progression in AMD sooner than with the Amsler grid. The key to the best outcome for treatment of wet AMD is early diagnosis and treatment. The ForeseeHomeª AMD Monitor by Notal Vision is approved by the [Read More]